Ionis Pharmaceuticals Quarterly Balance Sheet
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ionis Pharmaceuticals financial position
As of Jun 30, 2026, Ionis Pharmaceuticals reported total assets of $2.99 billion, up 0.3% from a year earlier against total liabilities of $2.55 billion. Shareholders' equity stood at $439.7 million, or 14.7% of assets. The company held $350.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.89, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Ionis Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q2 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 350.06M | 173.38M | 372.26M | 338.34M | 297.30M | 264.19M | 242.08M | 334.61M | 293.99M | 348.89M | 399.27M | 352.06M |
| Short-Term Investments | 1.70B | 1.75B | 2.31B | 1.90B | 1.99B | 1.88B | 2.06B | 2.15B | 1.78B | 1.86B | 1.93B | 1.88B |
| Inventory | 50.83M | 5.56M | 10.05M | 10.47M | 8.48M | 11.50M | 12.51M | 28.45M | 28.72M | 30.26M | 7.44M | 25.63M |
| Total Current Assets | 2.49B | 2.94B | 2.99B | 2.52B | 2.58B | 2.42B | 2.62B | 2.71B | 2.33B | 2.42B | 2.64B | 2.58B |
| Property, Plant & Equipment | 155.13M | 142.40M | 123.05M | 106.12M | 111.95M | 102.92M | 94.25M | 82.50M | 75.90M | 72.80M | 71.04M | 70.93M |
| Long-Term Investments | 647.33M | 630.67M | 773.71M | 700.94M | 718.35M | 681.35M | 652.54M | 689.95M | 460.84M | 568.16M | 653.49M | 546.86M |
| Total Assets | 2.99B | 3.45B | 3.52B | 3.03B | 2.99B | 2.81B | 3.00B | 3.08B | 2.69B | 2.76B | 2.99B | 2.93B |
| Accounts Payable | 47.70M | 26.03M | 28.08M | 14.33M | 22.80M | 17.46M | 42.96M | 9.05M | 9.24M | 13.08M | 26.03M | 5.62M |
| Short-Term Debt | — | — | 432.12M | — | — | — | 165.00K | — | — | — | 157.00K | — |
| Total Current Liabilities | 315.64M | 716.59M | 781.57M | 903.46M | 897.24M | 250.29M | 309.32M | 304.57M | 306.16M | 327.65M | 448.09M | 404.21M |
| Long-Term Debt | — | — | 1.33B | — | — | — | 1.20B | — | — | — | 1.24B | — |
| Total Liabilities | 2.55B | 2.96B | 3.03B | 2.42B | 2.35B | 2.34B | 2.42B | 2.42B | 2.43B | 2.47B | 2.60B | 2.62B |
| Shareholders' Equity | 439.74M | 491.41M | 489.09M | 617.97M | 631.72M | 475.73M | 588.35M | 662.47M | 263.70M | 296.51M | 386.69M | 315.46M |
| Retained Earnings | -2.84B | -2.72B | -2.63B | -2.40B | -2.27B | -2.40B | -2.25B | -2.15B | -2.00B | -1.94B | -1.80B | -1.79B |
| Total Debt | — | — | 1.76B | — | — | — | 1.20B | — | — | — | 1.24B | — |
| Net Cash (Debt) | 2.05B | 1.92B | 917.32M | 2.24B | 2.29B | 2.15B | 1.10B | 2.48B | 2.08B | 2.21B | 1.09B | 2.24B |
| Shares Outstanding | 165.64M | 165.90M | 163.30M | 161.14M | 159.20M | 159.04M | 157.91M | 157.81M | 146.03M | 145.84M | 144.34M | 143.39M |
This table shows 12 quarterly periods of Ionis Pharmaceuticals's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow IONS's reporting calendar. What is a balance sheet?